GIA
INSM icon

Gladstone Institutional Advisory’s Insmed INSM Stock Holding History

Gladstone Institutional Advisory’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,038
Closed -$740K – 706
2024
Q2 		$740K Buy
+11,038
New +$428K 0.04% 350

Other funds holding INSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Gladstone Institutional Advisory's INSM Position: Q3 2024 in Review

Gladstone Institutional Advisory sold out of Insmed (INSM) in Q3 2024, closing a stake of 11,038 shares — an estimated $740K sold.

Gladstone Institutional Advisory first reported a position in INSM in Q2 2024 and held it in 1 quarter. The position peaked at $740K in Q2 2024. 413 funds tracked by Wall St. Rank hold INSM as of Q3 2024.

  • Gladstone Institutional Advisory reported no remaining Insmed position as of Q3 2024 after selling out during the quarter.
  • Gladstone Institutional Advisory sold 11,038 Insmed shares in Q3 2024, an estimated $740K.
  • Gladstone Institutional Advisory first reported a position in Insmed in Q2 2024 and held it in 1 quarter.
  • Gladstone Institutional Advisory's Insmed position peaked at $740K in Q2 2024.
  • 413 funds tracked by Wall St. Rank held Insmed as of Q3 2024.

Based on Gladstone Institutional Advisory's 13F filing for Q3 2024, filed 28 Oct 2024.